Skip to main content
. 2014 Dec 2;47(3):441–447. doi: 10.4143/crt.2013.219

Table 3.

Adverse events

Adverse effect Grade
≤ 2 3 4 5
Hematologic adverse events
 Anemia 18 (51.4) 2 (5.7) 0 0
 Neutropenia 10 (28.6) 2 (5.7) 0 0
 Thrombocytopenia 10 (28.6) 2 (5.7) 0 0
Non-hematologic adverse events
 Stomatitis 6 (17.1) 29 (82.9) 0 0
 Dysphagia 31 (88.6) 3 (8.6) 0 0
 Emesis 8 (22.9) 0 1 (2.3) 0
 Infection 8 (22.9) 4 (11.4) 0 1 (2.3)a)
 Dermatitis 20 (57.2) 8 (22.9) 0 0
 Renal dysfunction 5 (14.3) 1 (2.3) 0 0
 Others 8 (22.9) 2 (5.7) 1 (2.3) 0
Persistent adverse events
 Xerostomia 25 (71.4) 2 (5.7) 0 0
 Dysphagia 20 (57.1) 0 0 0
 Neck fibrosis 7 (20.0) 0 0 0

Values are presented as number (%).

a)

Expired due to pneumonia with septic shock.